Related Experiment Video
Updated: Mar 29, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
14.7K
Challenges in pulmonary hypertension: managing the unexpected.
Karen M Olsson1, Massimiliano Palazzini2
1Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany Olsson.Karen@mh-hannover.de.
Summary
This review highlights challenges in diagnosing and managing pulmonary hypertension (PH). Effective treatment strategies for pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease require tailored approaches and ongoing patient evaluation.
Area of Science:
- Cardiology
- Pulmonology
- Rheumatology
Background:
- Pulmonary hypertension (PH) presents complex diagnostic and management challenges.
- Accurate diagnosis is crucial for effective treatment and improved patient outcomes.
Observation:
- Case 1: A patient with pulmonary arterial hypertension (PAH), right heart failure, and systemic lupus erythematosus (SLE) showed positive response to upfront triple PAH therapy and immunosuppression.
- Case 2: Pulmonary veno-occlusive disease (PVOD) was diagnosed using a multimodal approach, including clinical suspicion, physical exam, and diagnostic tests.
- PVOD management involved cautious PAH therapy and diuretics, facilitating lung transplantation.
Findings:
- Tailored therapeutic strategies are essential for managing diverse PH conditions.
- Integrated diagnostic approaches improve diagnostic accuracy for rare PH subtypes.
- Close patient monitoring and adaptive treatment plans are critical for long-term PH management.
Implications:
- These cases underscore the importance of individualized treatment plans for PH patients.
- Continuous diagnostic evaluation and treatment assessment are vital for optimizing care.
- Further research into optimal therapeutic combinations for complex PH cases is warranted.
More Related Videos
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
843
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
843
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
559
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
559
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
751
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
751
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
607
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
607
01:29Pulmonary Embolism I: Introduction
1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
656
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
656